The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of primary (1°) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti-epidermal growth factor receptor (αEGFR) therapy.
 
Michael Sangmin Lee
No Relationships to Disclose
 
Shailesh M Advani
No Relationships to Disclose
 
Jeffrey Morris
No Relationships to Disclose
 
Zhi-Qin Jiang
No Relationships to Disclose
 
Ganiraju C. Manyam
No Relationships to Disclose
 
David Menter
No Relationships to Disclose
 
Bradley McIntosh Broom
No Relationships to Disclose
 
Cathy Eng
Honoraria - Lilly; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech
Research Funding - ArQule; Keryx
Travel, Accommodations, Expenses - Genentech/Roche
 
Michael J. Overman
Consulting or Advisory Role - Merrimack; sirtex Medical
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche
 
Dipen M. Maru
No Relationships to Disclose
 
Stanley R. Hamilton
Consulting or Advisory Role - Amgen; Intervention Insights; Medical Research Council; Palmetto GBA
 
Scott Kopetz
Consulting or Advisory Role - Agendia; Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merrimack; Roche; Sanofi; Sysmex; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex